Session Title: Use of Toxin binders and Cholagogues (bile flow promoters) in Detoxification Protocols
Dr Christopher W. Shade obtained Bachelor of Science and Master of Science degrees from Lehigh University in environmental and aqueous chemistry. Dr Shade earned a PhD from the University of Illinois, where he studied the environmental and analytical chemistries of mercury as well as advanced aquatic chemistry. During his PhD work, Dr Shade patented analytical technology for mercury speciation analysis and later founded Quicksilver Scientific, LLC in order to commercialise this technology. Shortly after starting Quicksilver Scientific, Dr Shade turned his focus to the human aspects of mercury exposure/toxicity and the human detoxification system. He has since developed specific clinical analytical techniques for measuring mercury exposure and a system of products to remove metallic and organic toxins by upregulation of innate detoxification biochemistry. His current focus is at the intersection of neuro-inflammatory issues, immune dysregulation, toxicity, and infection – specifically how to peel away the layers of overlapping dysfunction in the sick individual until you get to a point at which the system rights itself.
November 3, 2018, 13:00 PM
Gut Brain 2018: Session 10–Use of Toxin binders and Cholagogues (bile flow promoters) in Detoxification ProtocolsGut Brain Relationship
- November 2, 2018, 09:30 AM Future of Medicine